Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts
Trial details
- Registry ID
- NCT00131872
- Drugs studied
- Expedial Vascular Access Graft
TrialRedline tracks 1 clinical trial sponsored by LeMaitre Vascular: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access GraftsNCT00131872 | Expedial Vascular Access Graft | Terminated | — |
Names as written in the registry records.